Charité Universitätsmedizin Berlin and Max Delbrück Center

Berlin

0 studies enrolling now · 2 studies all time

What they study most

Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)

Studies at this site

• Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9 — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) — Running, not enrolling